Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Santen files NDA for levofloxacin 1.5%

May 9, 2003

INS-37217 reported effective as adjunct in retinal reattachment surgery

May 9, 2003

Improved retinal thickness found with midostaurin in diabetic macular edema

May 8, 2003

Dry eye symptoms improve after transdermal application of testosterone cream

May 8, 2003

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

May 7, 2003

Roscovitine inhibits the proliferation of RPE cells

May 7, 2003

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

May 7, 2003

Approval and/or launch of major ophthalmic products reported by Allergan

May 5, 2003

Allergan and Acadia announce new drug discovery and development collaboration

May 5, 2003

ISV-403 moves into phase I clinical trials

May 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026